Literature DB >> 15736180

Serum leptin levels in Ache Amerindian females with normal adiposity are not significantly different from American anorexia nervosa patients.

Richard G Bribiescas1.   

Abstract

Serum leptin, a polypeptide hormone secreted primarily by adipocytes, is a reflection of somatic fat availability in humans and other vertebrates. Among Ache Amerindians, leptin levels are very low in contrast to other populations, despite comparable adiposity with individuals exhibiting much higher leptin levels. In order to gain a greater understanding of these differences, leptin levels were compared between Ache Amerindian females (n = 12, mean age = 32.2 +/- 14.0 SD), American females diagnosed with anorexia nervosa (n = 22, mean age = 23.0 +/- 4.0), and non-anorectic American controls (n = 23, mean age = 23.0 +/- 4.0). Ache leptin (5.6 +/- 3.2 ng/ml) was not significantly different from anorectic patients (5.6 +/- 3.7 ng/ml; P > 0.98) despite greater adiposity (Ache 33.3% +/- 4.4% vs. anorectic 7.0% +/- 2.0%; P < 0.0001). Ache adiposity was also higher than American controls (leptin 19.1 +/- 8.1 ng/ml; fat 28% +/- 5.0%; P < 0.004) underscoring the uniqueness of Ache leptin profiles. This suggests a greater range of population variation in leptin physiology than previously suspected and intimates the potential role of chronic environmental conditions. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15736180     DOI: 10.1002/ajhb.20108

Source DB:  PubMed          Journal:  Am J Hum Biol        ISSN: 1042-0533            Impact factor:   1.937


  2 in total

Review 1.  The blood-brain barrier as an endocrine tissue.

Authors:  William A Banks
Journal:  Nat Rev Endocrinol       Date:  2019-08       Impact factor: 43.330

2.  Population variation and differences in serum leptin independent of adiposity: a comparison of Ache Amerindian men of Paraguay and lean American male distance runners.

Authors:  Richard G Bribiescas; Matthew S Hickey
Journal:  Nutr Metab (Lond)       Date:  2006-08-30       Impact factor: 4.169

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.